• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株在特定背景下的出现与传播

Context-specific emergence and growth of the SARS-CoV-2 Delta variant.

作者信息

McCrone John T, Hill Verity, Bajaj Sumali, Pena Rosario Evans, Lambert Ben C, Inward Rhys, Bhatt Samir, Volz Erik, Ruis Christopher, Dellicour Simon, Baele Guy, Zarebski Alexander E, Sadilek Adam, Wu Neo, Schneider Aaron, Ji Xiang, Raghwani Jayna, Jackson Ben, Colquhoun Rachel, O'Toole Áine, Peacock Thomas P, Twohig Kate, Thelwall Simon, Dabrera Gavin, Myers Richard, Faria Nuno R, Huber Carmen, Bogoch Isaac I, Khan Kamran, du Plessis Louis, Barrett Jeffrey C, Aanensen David M, Barclay Wendy S, Chand Meera, Connor Thomas, Loman Nicholas J, Suchard Marc A, Pybus Oliver G, Rambaut Andrew, Kraemer Moritz U G

机构信息

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK.

contributed equally as first authors.

出版信息

medRxiv. 2021 Dec 21:2021.12.14.21267606. doi: 10.1101/2021.12.14.21267606.

DOI:10.1101/2021.12.14.21267606
PMID:34981069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8722612/
Abstract

The Delta variant of concern of SARS-CoV-2 has spread globally causing large outbreaks and resurgences of COVID-19 cases . The emergence of Delta in the UK occurred on the background of a heterogeneous landscape of immunity and relaxation of non-pharmaceutical interventions . Here we analyse 52,992 Delta genomes from England in combination with 93,649 global genomes to reconstruct the emergence of Delta, and quantify its introduction to and regional dissemination across England, in the context of changing travel and social restrictions. Through analysis of human movement, contact tracing, and virus genomic data, we find that the focus of geographic expansion of Delta shifted from India to a more global pattern in early May 2021. In England, Delta lineages were introduced >1,000 times and spread nationally as non-pharmaceutical interventions were relaxed. We find that hotel quarantine for travellers from India reduced onward transmission from importations; however the transmission chains that later dominated the Delta wave in England had been already seeded before restrictions were introduced. In England, increasing inter-regional travel drove Delta's nationwide dissemination, with some cities receiving >2,000 observable lineage introductions from other regions. Subsequently, increased levels of local population mixing, not the number of importations, was associated with faster relative growth of Delta. Among US states, we find that regions that previously experienced large waves also had faster Delta growth rates, and a model including interactions between immunity and human behaviour could accurately predict the rise of Delta there. Delta's invasion dynamics depended on fine scale spatial heterogeneity in immunity and contact patterns and our findings will inform optimal spatial interventions to reduce transmission of current and future VOCs such as Omicron.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的Delta变异毒株已在全球传播,导致新冠疫情大规模暴发和卷土重来。Delta毒株在英国出现时,英国的免疫状况参差不齐,非药物干预措施也有所放松。在此,我们分析了来自英格兰的52992个Delta毒株基因组,并结合93649个全球基因组,以重建Delta毒株的出现过程,并在旅行和社会限制不断变化的背景下,量化其传入英格兰的情况以及在英格兰各地区的传播情况。通过分析人员流动、接触者追踪和病毒基因组数据,我们发现,Delta毒株地理扩张的重点在2021年5月初从印度转移到了更为全球化的模式。在英格兰,随着非药物干预措施的放松,Delta毒株谱系被引入了1000多次并在全国范围内传播。我们发现,对来自印度的旅行者实施酒店隔离减少了输入病例的进一步传播;然而,后来在英格兰主导Delta毒株传播浪潮的传播链在限制措施实施之前就已经埋下了种子。在英格兰,区域间旅行的增加推动了Delta毒株在全国范围内的传播,一些城市从其他地区接收到超过2000次可观察到的谱系引入。随后,当地人群混合程度的增加,而非输入病例的数量,与Delta毒株相对更快的增长相关。在美国各州,我们发现之前经历过大规模疫情浪潮的地区Delta毒株的增长率也更快,一个包括免疫与人类行为相互作用的模型可以准确预测Delta毒株在那里的增长情况。Delta毒株的入侵动态取决于免疫和接触模式的精细空间异质性,我们的研究结果将为减少当前和未来诸如奥密克戎等变异新冠病毒传播的最佳空间干预措施提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/bc3a2adef779/nihpp-2021.12.14.21267606v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/14804d12139a/nihpp-2021.12.14.21267606v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/2ac7d75b19bc/nihpp-2021.12.14.21267606v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/b5b4506d7d27/nihpp-2021.12.14.21267606v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/c9e6544fcc16/nihpp-2021.12.14.21267606v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/75f986dbc208/nihpp-2021.12.14.21267606v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/370642ae2304/nihpp-2021.12.14.21267606v1-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/0c63e207b396/nihpp-2021.12.14.21267606v1-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/2be9a0781cda/nihpp-2021.12.14.21267606v1-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/c8f7dbdf1b6f/nihpp-2021.12.14.21267606v1-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/4109b3c89b92/nihpp-2021.12.14.21267606v1-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/9a40ce11361d/nihpp-2021.12.14.21267606v1-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/89231dd82131/nihpp-2021.12.14.21267606v1-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/6c8537eb26be/nihpp-2021.12.14.21267606v1-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/d37fc7ed465b/nihpp-2021.12.14.21267606v1-f0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/6f04b4493392/nihpp-2021.12.14.21267606v1-f0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/067d77c32b52/nihpp-2021.12.14.21267606v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/e7c62ac5e754/nihpp-2021.12.14.21267606v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/78e7a41946cf/nihpp-2021.12.14.21267606v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/bc3a2adef779/nihpp-2021.12.14.21267606v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/14804d12139a/nihpp-2021.12.14.21267606v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/2ac7d75b19bc/nihpp-2021.12.14.21267606v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/b5b4506d7d27/nihpp-2021.12.14.21267606v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/c9e6544fcc16/nihpp-2021.12.14.21267606v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/75f986dbc208/nihpp-2021.12.14.21267606v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/370642ae2304/nihpp-2021.12.14.21267606v1-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/0c63e207b396/nihpp-2021.12.14.21267606v1-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/2be9a0781cda/nihpp-2021.12.14.21267606v1-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/c8f7dbdf1b6f/nihpp-2021.12.14.21267606v1-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/4109b3c89b92/nihpp-2021.12.14.21267606v1-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/9a40ce11361d/nihpp-2021.12.14.21267606v1-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/89231dd82131/nihpp-2021.12.14.21267606v1-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/6c8537eb26be/nihpp-2021.12.14.21267606v1-f0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/d37fc7ed465b/nihpp-2021.12.14.21267606v1-f0018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/6f04b4493392/nihpp-2021.12.14.21267606v1-f0019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/067d77c32b52/nihpp-2021.12.14.21267606v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/e7c62ac5e754/nihpp-2021.12.14.21267606v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/78e7a41946cf/nihpp-2021.12.14.21267606v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dd4/8722612/bc3a2adef779/nihpp-2021.12.14.21267606v1-f0004.jpg

相似文献

1
Context-specific emergence and growth of the SARS-CoV-2 Delta variant.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株在特定背景下的出现与传播
medRxiv. 2021 Dec 21:2021.12.14.21267606. doi: 10.1101/2021.12.14.21267606.
2
Context-specific emergence and growth of the SARS-CoV-2 Delta variant.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Delta变异株在特定背景下的出现与传播
Res Sq. 2021 Dec 20:rs.3.rs-1159614. doi: 10.21203/rs.3.rs-1159614/v1.
3
Context-specific emergence and growth of the SARS-CoV-2 Delta variant.SARS-CoV-2 德尔塔变异株的出现与增长具有特定情境性。
Nature. 2022 Oct;610(7930):154-160. doi: 10.1038/s41586-022-05200-3. Epub 2022 Aug 11.
4
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
5
Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air Travel.关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种的全球传播:传播模式及航空旅行的影响
medRxiv. 2022 Nov 27:2022.11.22.22282629. doi: 10.1101/2022.11.22.22282629.
6
Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.Delta 变异株在巴西不同地区的出现和传播
Microbiol Spectr. 2022 Oct 26;10(5):e0264121. doi: 10.1128/spectrum.02641-21. Epub 2022 Aug 24.
7
Community transmission of SARS-CoV-2 during the Delta wave in New York City.在纽约市德尔塔波期间,SARS-CoV-2 的社区传播。
BMC Infect Dis. 2023 Nov 2;23(1):753. doi: 10.1186/s12879-023-08735-6.
8
Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.加拿大 SARS-CoV-2 前两波的基因组流行病学。
Elife. 2022 Aug 2;11:e73896. doi: 10.7554/eLife.73896.
9
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
10
Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US.美国佛罗里达州 SARS-CoV-2 德尔塔变异株的早期出现阶段。
Viruses. 2022 Apr 6;14(4):766. doi: 10.3390/v14040766.

本文引用的文献

1
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.美国新英格兰地区 SARS-CoV-2 变异株 Delta 和 Alpha 的比较传染性。
Cell Rep Med. 2022 Mar 11;3(4):100583. doi: 10.1016/j.xcrm.2022.100583. eCollection 2022 Apr 19.
2
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.具有增强传播性和/或部分免疫逃逸能力的 SARS-CoV-2 变异株对人群的影响。
Cell. 2021 Dec 22;184(26):6229-6242.e18. doi: 10.1016/j.cell.2021.11.026. Epub 2021 Nov 19.
3
Monitoring key epidemiological parameters of SARS-CoV-2 transmission.
监测新冠病毒传播的关键流行病学参数。
Nat Med. 2021 Nov;27(11):1854-1855. doi: 10.1038/s41591-021-01545-w.
4
Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles.利用病毒样颗粒快速评估 SARS-CoV-2 进化变体。
Science. 2021 Dec 24;374(6575):1626-1632. doi: 10.1126/science.abl6184. Epub 2021 Nov 4.
5
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.Delta 变异株导致的指数级增长、高 SARS-CoV-2 流行率和疫苗效力。
Science. 2021 Dec 17;374(6574):eabl9551. doi: 10.1126/science.abl9551.
6
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.
7
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant.SARS-CoV-2 Delta 变异株刺突蛋白介导的膜融合与免疫逃逸。
Science. 2021 Dec 10;374(6573):1353-1360. doi: 10.1126/science.abl9463. Epub 2021 Oct 26.
8
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.感染 SARS-CoV-2 及关注变异株后康复患者血清中的中和抗体活性。
Nat Microbiol. 2021 Nov;6(11):1433-1442. doi: 10.1038/s41564-021-00974-0. Epub 2021 Oct 15.
9
Genomic reconstruction of the SARS-CoV-2 epidemic in England.英格兰地区 SARS-CoV-2 疫情的基因组重建。
Nature. 2021 Dec;600(7889):506-511. doi: 10.1038/s41586-021-04069-y. Epub 2021 Oct 14.
10
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.印度德里地区一种新型 SARS-CoV-2 变体的基因组特征和流行病学研究。
Science. 2021 Nov 19;374(6570):995-999. doi: 10.1126/science.abj9932. Epub 2021 Oct 14.